nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC7A5—Amino acid transport across the plasma membrane—SLC3A1—nephrolithiasis	0.0725	0.0959	CbGpPWpGaD
Melphalan—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0561	0.0742	CbGpPWpGaD
Melphalan—SLC7A5—Basigin interactions—SLC7A9—nephrolithiasis	0.054	0.0715	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0502	0.0665	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid transport across the plasma membrane—SLC7A9—nephrolithiasis	0.0455	0.0602	CbGpPWpGaD
Melphalan—Sensation of warmth—Hydrochlorothiazide—nephrolithiasis	0.0334	0.137	CcSEcCtD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.0323	0.0428	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.0315	0.0418	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0296	0.0391	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0296	0.0391	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.0224	0.0297	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.0208	0.0276	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.0186	0.0246	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SLC7A9—nephrolithiasis	0.018	0.0238	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0145	0.0191	CbGpPWpGaD
Melphalan—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0579	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0132	0.0175	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0132	0.0175	CbGpPWpGaD
Melphalan—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0535	CcSEcCtD
Melphalan—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0469	CcSEcCtD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0112	0.0149	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0104	0.0138	CbGpPWpGaD
Melphalan—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0416	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.01	0.0133	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.01	0.0133	CbGpPWpGaD
Melphalan—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0097	0.0397	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00931	0.0123	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00931	0.0123	CbGpPWpGaD
Melphalan—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00922	0.0377	CcSEcCtD
Melphalan—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00916	0.0375	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0083	0.011	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00824	0.0109	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00824	0.0109	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00736	0.00974	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00734	0.00972	CbGpPWpGaD
Melphalan—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00724	0.0296	CcSEcCtD
Melphalan—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00689	0.0282	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00673	0.00891	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00673	0.00891	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00672	0.00889	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00672	0.00889	CbGpPWpGaD
Melphalan—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00656	0.0268	CcSEcCtD
Melphalan—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00603	0.0247	CcSEcCtD
Melphalan—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00528	0.0216	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0051	0.00675	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0051	0.00675	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00509	0.00674	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00509	0.00674	CbGpPWpGaD
Melphalan—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00494	0.0202	CcSEcCtD
Melphalan—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0201	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SLC7A9—nephrolithiasis	0.00487	0.00645	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—DGKH—nephrolithiasis	0.00487	0.00645	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00474	0.00628	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00474	0.00628	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00473	0.00626	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00473	0.00626	CbGpPWpGaD
Melphalan—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00452	0.0185	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00423	0.0056	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00422	0.00558	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00422	0.00558	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0042	0.00556	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0042	0.00556	CbGpPWpGaD
Melphalan—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00419	0.0172	CcSEcCtD
Melphalan—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00404	0.0165	CcSEcCtD
Melphalan—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00399	0.0163	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00374	0.00495	CbGpPWpGaD
Melphalan—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00364	0.0149	CcSEcCtD
Melphalan—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00352	0.0144	CcSEcCtD
Melphalan—Cough—Hydrochlorothiazide—nephrolithiasis	0.00343	0.014	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00342	0.00453	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00342	0.00453	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00337	0.00446	CbGpPWpGaD
Melphalan—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00335	0.0137	CcSEcCtD
Melphalan—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00335	0.0137	CcSEcCtD
Melphalan—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00321	0.0131	CcSEcCtD
Melphalan—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00321	0.0131	CcSEcCtD
Melphalan—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00314	0.0129	CcSEcCtD
Melphalan—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00313	0.0128	CcSEcCtD
Melphalan—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00306	0.0125	CcSEcCtD
Melphalan—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.003	0.0123	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00293	0.012	CcSEcCtD
Melphalan—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00288	0.0118	CcSEcCtD
Melphalan—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00286	0.0117	CcSEcCtD
Melphalan—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.0116	CcSEcCtD
Melphalan—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00279	0.0114	CcSEcCtD
Melphalan—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00277	0.0113	CcSEcCtD
Melphalan—Pain—Hydrochlorothiazide—nephrolithiasis	0.00275	0.0112	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00259	0.00343	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00259	0.00343	CbGpPWpGaD
Melphalan—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00255	0.0104	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00241	0.00319	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00241	0.00319	CbGpPWpGaD
Melphalan—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00968	CcSEcCtD
Melphalan—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00942	CcSEcCtD
Melphalan—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00929	CcSEcCtD
Melphalan—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00899	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00215	0.00284	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00215	0.00284	CbGpPWpGaD
Melphalan—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00835	CcSEcCtD
Melphalan—Rash—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00828	CcSEcCtD
Melphalan—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00827	CcSEcCtD
Melphalan—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0078	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00172	0.00227	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GRHPR—nephrolithiasis	0.00149	0.00197	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AGXT—nephrolithiasis	0.00133	0.00176	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC26A1—nephrolithiasis	0.00113	0.00149	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APRT—nephrolithiasis	0.00113	0.00149	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AQP1—nephrolithiasis	0.000804	0.00106	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CHRM3—nephrolithiasis	0.000728	0.000963	CbGpPWpGaD
